Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 104 articles:
HTML format
Text format



Single Articles


    July 2018
  1. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    HIV.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    PubMed     Text format     Abstract available


  2. BAROUCH DH, Tomaka FL, Wegmann F, Stieh DJ, et al
    Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Lancet. 2018;392:232-243.
    PubMed     Text format     Abstract available


  3. PAVLAKIS GN, Felber BK
    A new step towards an HIV/AIDS vaccine.
    Lancet. 2018;392:192-194.
    PubMed     Text format    


  4. SHANNON K, Crago AL, Baral SD, Bekker LG, et al
    The global response and unmet actions for HIV and sex workers.
    Lancet. 2018 Jul 20. pii: S0140-6736(18)31439.
    PubMed     Text format     Abstract available


  5. DAS P, Horton R
    Beyond the silos: integrating HIV and global health.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31466.
    PubMed     Text format    


  6. MAKOFANE K, Spire B, Mtetwa P
    Tackling global health inequities in the HIV response.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31441.
    PubMed     Text format    


  7. SANDS P
    HIV: from exceptionalism to endgame.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31434.
    PubMed     Text format    


  8. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available


  9. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    


  10. BEKKER LG, Alleyne G, Baral S, Cepeda J, et al
    Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31070.
    PubMed     Text format    


    June 2018
  11. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed     Text format    


  12. MCBRIDE B, Mitra S, Kondo V, Elmi H, et al
    Unpaid labour, #MeToo, and young women in global health.
    Lancet. 2018;391:2192-2193.
    PubMed     Text format    


    May 2018
  13. NISHTAR S, Niinisto S, Sirisena M, Vazquez T, et al
    Time to deliver: report of the WHO Independent High-Level Commission on NCDs.
    Lancet. 2018 May 31. pii: S0140-6736(18)31258.
    PubMed     Text format    


  14. ZAROCOSTAS J
    HIV/AIDS community divided over allegations about UNAIDS.
    Lancet. 2018;391:1984.
    PubMed     Text format    


    April 2018

  15. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Lancet. 2018 Apr 17. pii: S0140-6736(18)30698.
    PubMed     Text format     Abstract available


    March 2018
  16. OLAKUNDE BO, Adeyinka DA, Wakdok SS, Oladele TT, et al
    Quantification of the effect of terrorism on the HIV response in Nigeria.
    Lancet. 2018;391:1257-1258.
    PubMed     Text format    


  17. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    


  18. BROWNE JL, Smit MR, Angira F, van der Graaf R, et al
    Good intentions do not replace ethical conduct in research.
    Lancet. 2018;391:1020-1021.
    PubMed     Text format    


    February 2018
  19. THAPA S
    Women helping women prevent HIV in resource-limited settings.
    Lancet. 2018;391:738-739.
    PubMed     Text format    


    January 2018
  20. LLIBRE JM, Hung CC, Brinson C, Castelli F, et al
    Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
    Lancet. 2018 Jan 5. pii: S0140-6736(17)33095.
    PubMed     Text format     Abstract available


  21. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    PubMed     Text format     Abstract available


    December 2017
  22. BERNARDO EL, Fuente-Soro L, Lopez-Varela E, Naniche D, et al
    Anonymity in HIV testing: implications for public health.
    Lancet. 2017;390:2546.
    PubMed     Text format    


    October 2017
  23. LAMONTAGNE F, Fowler RA, Adhikari NK, Murthy S, et al
    Evidence-based guidelines for supportive care of patients with Ebola virus disease.
    Lancet. 2017 Oct 17. pii: S0140-6736(17)31795.
    PubMed     Text format     Abstract available


  24. IYER JK, Mendelson M
    Can the Antimicrobial Resistance Benchmark blaze a new trail?
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32670.
    PubMed     Text format    


    September 2017
  25. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


  26. KAZATCHKINE MD
    Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.
    Lancet. 2017;390:1611-1612.
    PubMed     Text format    



  27. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1151-1210.
    PubMed     Text format     Abstract available



  28. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1084-1150.
    PubMed     Text format     Abstract available


    August 2017
  29. SAX PE, Pozniak A, Montes ML, Koenig E, et al
    Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-infer
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32340.
    PubMed     Text format     Abstract available


  30. BOFFITO M, Venter F
    The triumph of HIV treatment: another new antiretroviral.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32297.
    PubMed     Text format    


  31. GALLANT J, Lazzarin A, Mills A, Orkin C, et al
    Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32299.
    PubMed     Text format     Abstract available


  32. GREEN A
    President of Zambia declares HIV testing mandatory.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32295.
    PubMed     Text format    


  33. THE LANCET
    Losing the fight against HIV in the Philippines.
    Lancet. 2017;390:626.
    PubMed     Text format    


    July 2017
  34. KARIM SSA, Karim QA, Abimiku A, Bekker LG, et al
    Closing the NIH Fogarty Center threatens US and global health.
    Lancet. 2017;390:451.
    PubMed     Text format    


  35. HODSON N, Bewley S
    Nelly Mugo and the response to HIV: more than just PrEP advocacy.
    Lancet. 2017;390:358.
    PubMed     Text format    


  36. GREEN A
    The HIV response in Ukraine: at a crossroads.
    Lancet. 2017;390:347-348.
    PubMed     Text format    


  37. BEYRER C, Das P, Horton R, Ryan O, et al
    The International AIDS Society-Lancet Commission on the future of the HIV response and global health.
    Lancet. 2017;390:344-345.
    PubMed     Text format    


  38. GRANICH R, Williams B, Montaner J, Zuniga JM, et al
    90-90-90 and ending AIDS: necessary and feasible.
    Lancet. 2017;390:341-343.
    PubMed     Text format    


  39. THE LANCET
    The global HIV/AIDS epidemic-progress and challenges.
    Lancet. 2017;390:333.
    PubMed     Text format    


  40. BOYD MA, Cooper DA
    Long-acting injectable ART: next revolution in HIV?
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31962.
    PubMed     Text format    


  41. MARGOLIS DA, Gonzalez-Garcia J, Stellbrink HJ, Eron JJ, et al
    Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31917.
    PubMed     Text format     Abstract available


    March 2017
  42. DANIELS JP
    Venezuela's economic crisis hampers HIV/AIDS treatment.
    Lancet. 2017;389:1088-1089.
    PubMed     Text format    


  43. HUFFMAN MD, Xavier D, Perel P
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet. 2017;389:1055-1065.
    PubMed     Text format     Abstract available


  44. MENDENHALL E, Kohrt BA, Norris SA, Ndetei D, et al
    Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.
    Lancet. 2017;389:951-963.
    PubMed     Text format     Abstract available


  45. MOHAMMADI D
    Growing older with HIV in the UK.
    Lancet. 2017;389:894-895.
    PubMed     Text format    


    February 2017
  46. DOWNS JA, Mwakisole AH, Chandika AB, Lugoba S, et al
    Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial.
    Lancet. 2017 Feb 14. pii: S0140-6736(16)32055.
    PubMed     Text format     Abstract available


    January 2017
  47. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


  48. SHIELS MS, Chernyavskiy P, Anderson WF, Best AF, et al
    Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.
    Lancet. 2017 Jan 25. pii: S0140-6736(17)30187.
    PubMed     Text format     Abstract available


  49. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available


    December 2016
  50. ZHU FC, Wurie AH, Hou LH, Liang Q, et al
    Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32617.
    PubMed     Text format     Abstract available


  51. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Text format     Abstract available


    November 2016
  52. DAS P
    Deborah L Birx: on a mission to end the HIV/AIDS epidemic.
    Lancet. 2016;388:2583.
    PubMed     Text format    


  53. KIRBY T
    Targeting HIV prevention to young women in Africa.
    Lancet. 2016;388:2579.
    PubMed     Text format    


  54. KIRBY T
    David Cooper: Australia's fighter against HIV and discrimination.
    Lancet. 2016;388:2469.
    PubMed     Text format    


  55. YANG YT, Wiley E, Duvivier RJ
    US policy on blood donation by men who have sex with men.
    Lancet. 2016;388:2236-2237.
    PubMed     Text format    


    October 2016
  56. HONORE JG, Balan JG, Thimothe G, Diallo J, et al
    Instability adversely affects HIV care in Haiti.
    Lancet. 2016;388:1877.
    PubMed     Text format    


  57. GREEN A
    NIH project focuses on integration of HIV and NCD care.
    Lancet. 2016;388:1869.
    PubMed     Text format    



  58. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1775-1812.
    PubMed     Text format     Abstract available



  59. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1545-1602.
    PubMed     Text format     Abstract available



  60. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1459-1544.
    PubMed     Text format     Abstract available


  61. QIN Y, Liu F, Tang W, Tang S, et al
    HIV self-testing among high-risk men who have sex with men in China: a cross-sectional study.
    Lancet. 2016;388 Suppl 1:S76.
    PubMed     Text format     Abstract available


  62. MAO J, Tang W, Liu C, Wong NS, et al
    Sex tourism among Chinese men who have sex with men: a cross-sectional observational study.
    Lancet. 2016;388 Suppl 1:S75.
    PubMed     Text format     Abstract available


  63. TANG S, Tang W, Meyers K, Chan P, et al
    HIV and syphilis among men who have sex with men and transgender individuals in China: a scoping review.
    Lancet. 2016;388 Suppl 1:S74.
    PubMed     Text format     Abstract available


  64. TANG W, Mao J, Liu C, Mollan K, et al
    Crowdsourcing health communication about condom use in men who have sex with men in China: a randomised controlled trial.
    Lancet. 2016;388 Suppl 1:S73.
    PubMed     Text format     Abstract available


  65. ZHAO P, Tang S, Wang C, Zhang Y, et al
    Recreational drug use among Chinese MSM: results from a national-wide cross-sectional study.
    Lancet. 2016;388 Suppl 1:S69.
    PubMed     Text format     Abstract available


  66. TANG W, Mao J, Tang S, Liu C, et al
    Disclosure of sexual orientation in men who have sex with men in China: a cross-sectional survey.
    Lancet. 2016;388 Suppl 1:S68.
    PubMed     Text format     Abstract available


  67. SMITH MK, Miller WC, Liu H, Ning C, et al
    Effects of patient load and travel distance on HIV transmission in a cohort of serodiscordant couples in rural China: a longitudinal analysis.
    Lancet. 2016;388 Suppl 1:S65.
    PubMed     Text format     Abstract available


  68. WONG NS, Wong KH, Tsang OT, Lee MP, et al
    HIV testing campaigns and treatment interventions for control of epidemic HIV growth among heterosexuals: a mathematical modelling study.
    Lancet. 2016;388 Suppl 1:S49.
    PubMed     Text format     Abstract available


  69. KWAN TH, Poon CM, Wong KH, Lee SS, et al
    Effects of HIV diagnosis and enrolment in care on transmission risk of HIV-infected men who have sex with men in Hong Kong: a cross-sectional study.
    Lancet. 2016;388 Suppl 1:S48.
    PubMed     Text format     Abstract available


  70. NING C, Smith KM, McCann CD, Hu F, et al
    Mortality and retention in hospital-based and CDC-based antiretroviral service delivery in people living with HIV in the Guangdong Province, China: a prospective cohort study.
    Lancet. 2016;388 Suppl 1:S26.
    PubMed     Text format     Abstract available


  71. WONG WC, Jiang S, Ong J, Peng M, et al
    Availability and use of primary care facilities in China: a nationwide representative survey.
    Lancet. 2016;388 Suppl 1:S18.
    PubMed     Text format     Abstract available


    September 2016
  72. HADLAND SE, Wood E, Levy S
    How the paediatric workforce can address the opioid crisis.
    Lancet. 2016;388:1260-1.
    PubMed     Text format    



  73. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.
    Lancet. 2016 Sep 19. pii: S0140-6736(16)31467.
    PubMed     Text format     Abstract available


  74. PAN SW, Li D, Carpiano RM, Spittal PM, et al
    Ethnicity and HIV epidemiology research in China.
    Lancet. 2016;388:1052-3.
    PubMed     Text format    


  75. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    


    August 2016
  76. CLARK F
    Gaps remain in Russia's response to HIV/AIDS.
    Lancet. 2016;388:857-8.
    PubMed     Text format    


  77. PERSAD GC, Emanuel EJ
    The ethics of expanding access to cheaper, less effective treatments.
    Lancet. 2016;388:932-4.
    PubMed     Text format    


  78. POKU NK
    UN political declaration on HIV and AIDS: where to begin?
    Lancet. 2016;388:743-744.
    PubMed     Text format    



  79. NHS England: preparing for PrEP.
    Lancet. 2016;388:634.
    PubMed     Text format    



  80. Reassessing blood donation by men who have sex with men.
    Lancet. 2016;388:534.
    PubMed     Text format    


  81. KROIDL I, Saathof E, Maganga L, Makunde WH, et al
    Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study.
    Lancet. 2016 Aug 2. pii: S0140-6736(16)31252.
    PubMed     Text format     Abstract available


  82. DOWNS JA, Fitzgerald DW
    No more neglect of helminths and HIV.
    Lancet. 2016 Aug 2. pii: S0140-6736(16)31253.
    PubMed     Text format    


    July 2016
  83. RUBIN R
    US prisons missing opportunities to tackle HIV in inmates.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)31078.
    PubMed     Text format    


  84. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available


  85. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available


  86. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available


  87. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


  88. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  89. SHRAGE L
    African Americans, HIV, and mass incarceration.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30830.
    PubMed     Text format    


  90. DAS P, Horton R
    On both sides of the prison walls-prisoners and HIV.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30892.
    PubMed     Text format    


  91. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    PubMed     Text format     Abstract available


  92. BEYRER C, Kamarulzaman A, McKee M
    Prisoners, prisons, and HIV: time for reform.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30829.
    PubMed     Text format    


  93. BEYRER C, Baral SD, Collins C, Richardson ET, et al
    The global response to HIV in men who have sex with men.
    Lancet. 2016;388:198-206.
    PubMed     Text format     Abstract available


  94. WIKTOR SZ, Hutin YJ
    The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)31018.
    PubMed     Text format    


    June 2016
  95. WYLIE K, Knudson G, Khan SI, Bonierbale M, et al
    Serving transgender people: clinical care considerations and service delivery models in transgender health.
    Lancet. 2016 Jun 16. pii: S0140-6736(16)00682.
    PubMed     Text format     Abstract available


  96. REISNER SL, Poteat T, Keatley J, Cabral M, et al
    Global health burden and needs of transgender populations: a review.
    Lancet. 2016 Jun 16. pii: S0140-6736(16)00684.
    PubMed     Text format     Abstract available


  97. GUISE A
    Next generation of comprehensive HIV prevention.
    Lancet. 2016;387:2377-8.
    PubMed     Text format    


  98. SIDIBE M, Singh PK
    Thailand eliminates mother-to-child transmission of HIV and syphilis.
    Lancet. 2016 Jun 9. pii: S0140-6736(16)30787.
    PubMed     Text format    


    May 2016
  99. LOMBARD C, Cousens S, Tylleskar T, Van de Perre P, et al
    Trial size, HIV pre-exposure prophylaxis, and breastfeeding - Authors' reply.
    Lancet. 2016;387:2091.
    PubMed     Text format    


  100. BIRD SM
    Trial size, HIV pre-exposure prophylaxis, and breastfeeding.
    Lancet. 2016;387:2090-1.
    PubMed     Text format    


  101. SHAPIRO R, Dryden-Peterson S, Powis K, Zash R, et al
    Hidden in plain sight: HIV, antiretrovirals, and stillbirths.
    Lancet. 2016;387:1994-1995.
    PubMed     Text format    


  102. MOKDAD AH, Forouzanfar MH, Daoud F, Mokdad AA, et al
    Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016 May 9. pii: S0140-6736(16)00648.
    PubMed     Text format     Abstract available


    April 2016
  103. ADAMS P
    Cryptococcal meningitis: a blind spot in curbing AIDS.
    Lancet. 2016;387:1605-6.
    PubMed     Text format    


  104. SNYDER A
    Willard Cates, Jr.
    Lancet. 2016;387:1506.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: